video thumbnail

Aspirin Indications (Pharma Mastery Lecture 2)

Duration: 45:44

Write A New Comment

0 Comments

In this lecture we will continue our discussion for Aspirin. We have already discussed the mechanism of actions of Aspirin. Today we will discuss the therapeutic indications for aspiring and review various studies that demonstrate evidence for this usage. Following topics will be discussed:

Aspirin for primary and secondary prevention of cardiovascular disease (CVD)

Aspirin and NSAIDs for inflammation, pain, and fever.

Systemic mastocytosis.

Niacin tolerability.

Aspirin and colorectal cancer.

Objectives:

Discuss the major therapeutic uses of aspirin, including its analgesic, anti-inflammatory, antipyretic, and antiplatelet effects.

Identify and explain the potential adverse effects of aspirin, including gastrointestinal complications and Reye's syndrome.

Compare and contrast the benefits and risks of aspirin use in various patient populations.

Recognize the importance of aspirin in preventive medicine, particularly in cardiovascular disease.

Systemic Mastocytosis Symptoms, Diagnosis, Treatment & Management
https://www.aaaai.org/conditions-treatments/related-conditions/systemic-mastocytosis

Survey of Aspirin Administration in Systemic Mastocytosis - Journal of Allergy and Clinical Immunology
https://www.jacionline.org/article/S0091-6749(08)03167-9/fulltext#:~:text=CONCLUSIONS%3A%20The%20majority%20of%20SM,for%20aspirin%20or%20NSAID%20intolerance.

jgi_7118.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1497169/pdf/jgi_7118.pdf

Aspirin Use and Risk of Colorectal Cancer Among Older Adults | Cancer Screening, Prevention, Control | JAMA Oncology | JAMA Network
https://jamanetwork.com/journals/jamaoncology/fullarticle/2775175#:~:text=Aspirin%20is%20considered%20the%20most,with%20specific%20cardiovascular%20risk%20profiles.

Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement | Cardiovascular Risk Factors | JAMA | JAMA Network
https://jamanetwork.com/journals/jama/fullarticle/2791399#:~:text=The%20ACC%2FAHA%20recommends%20that,at%20increased%20risk%20of%20bleeding.

Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach | Arteriosclerosis, Thrombosis, and Vascular Biology
https://www.ahajournals.org/doi/10.1161/ATVBAHA.122.318020

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease | Journal of the American Heart Association
https://www.ahajournals.org/doi/10.1161/JAHA.122.026921

Discuss the major therapeutic uses of aspirin, including its analgesic, anti-inflammatory, antipyretic, and antiplatelet effects.

Identify and explain the potential adverse effects of aspirin, including gastrointestinal complications and Reye's syndrome.

Compare and contrast the benefits and risks of aspirin use in various patient populations.

Recognize the importance of aspirin in preventive medicine, particularly in cardiovascular disease.

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Faculty

In addition to the presenter, following authors may have helped with the content writing, review, or approval:

  • Dr. Mobeen Syed

CME, CE, CEU and Other Credit Types:

ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Information

In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for Continuing Medical Education), we are committed to upholding principles of balance, independence, objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing Education (CE) activities. These policies include the careful management and mitigation of any relevant financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined that these relationships are not deemed inappropriate in the context of their respective presentations. Additionally, they are found to be consistent with the educational objectives and the integrity of the activity.

Faculty Disclosures
Dr. Mobeen Syed Author declares no conflict of interest.

Please login to access this content.

Don't have an account?

See Plans

Instructors

Dr. Mobeen Syed

Dr. Mobeen Syed

MD., MSc., MSc., BSc

Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.

Pharma Mastery

Related Videos